The Company Aura Biosciences Inc (United States), is listed on Nasdaq with a market value of $ 413.82 Millions, having an equity of $ 156.67 Millions.
The Company is listedthe in the sector of Others and categorized in industry of Others.
In the last 12 months the Company had a revenue of $ -, which generated a loss in the amount of $ -106.46 Millions.
As for its main indicators, the Company has a P/E ratio of -3.89, a P/BV ratio of 2.64 and in the last 12 months the Company did not pay dividends.
The Company is traded internationally through the ticker AURA.